Efficacy and safety of trabectedin or dacarbazine for the treatment of patients with uterine leiomyosarcoma after prior chemotherapy: A subgroup analysis of the randomized phase 3 SAR-3007 study

Efficacy and safety of trabectedin or dacarbazine for the treatment of patients with uterine leiomyosarcoma after prior chemotherapy: A subgroup analysis of the randomized phase 3 SAR-3007 study

Saved in:
Bibliographic Details
Published in:Gynecologic oncology Vol. 141; p. 3
Main Authors: Hensley, M.L, Patel, S.R, Mehren, M.V, Ganjoo, K, Jones, R.L, Staddon, A.P, Rushing, D, Milhem, M, Monk, B.J, Wang, G, McCarthy, S, Knoblauch, R, Parekh, T, Maki, R.G, Demetri, G.D
Format: Journal Article
Language:English
Published: Elsevier Inc 01-06-2016
Subjects:
Hematology, Oncology and Palliative Medicine
Obstetrics and Gynecology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2016.04.035